Anti-ly6g6d antibodies and methods of use
AssigneeGenentech, Inc.
InventorsWeiYu LIN, Christoph SPIESS, Liping SUN, Yan WU, Cecilia P.C. CHIU, Walter Christian DARBONNE, Michael Andrew DILLON
Life of this patent
Estimating the term…
Abstract
Provided herein are anti-Ly6G6D (lymphocyte antigen 6 complex, locus G61) antibodies and methods of using the same.
Claims26
1-166. (canceled)
An isolated antibody that binds to lymphocyte antigen 6 family member G6D (LY6G6D), wherein the antibody comprises a LY6G6D binding domain comprising a heavy chain polypeptide (H1) and a light chain polypeptide (L1), wherein the H1 comprises a heavy chain variable (VH) domain (VH1) comprising the following complementarity determining regions (CDRs):
- (a) a CDR-H1 comprising the amino acid sequence of SEQ ID NO:
- 4;
- (b) a CDR-H2 comprising the amino acid sequence of SEQ ID NO:
- 5;
- and
- (c) a CDR-H3 comprising the amino acid sequence of SEQ ID NO:
- 6;
- and
- the L1 comprises a light chain variable (VL) domain (VL1) comprising the following CDRs:
- (d) a CDR-L1 comprising the amino acid sequence of SEQ ID NO:
- 1;
- (e) a CDR-L2 comprising the amino acid sequence of SEQ ID NO:
- 2;
- and
- (f) a CDR-L3 comprising the amino acid sequence of SEQ ID NO:
- 3.
An isolated antibody that binds to LY6G6D, wherein the antibody comprises a LY6G6D binding domain comprising a heavy chain polypeptide (H1) and a light chain polypeptide (L1), wherein:
- (a) the H1 comprises a VH domain (VH1) comprising the amino acid sequence of SEQ ID NO:
- 10 and the L1 comprises a VL domain (VL1) comprising the amino acid sequence of SEQ ID NO:
- 11;
- or
- (b) the H1 comprises a VH domain (VH1) comprising the amino acid sequence of SEQ ID NO:
- 59 and the L1 comprises a VL domain (VL1) comprising the amino acid sequence of SEQ ID NO:
- 60.
An isolated antibody that binds to LY6G6D, wherein the antibody comprises a LY6G6D binding domain comprising a heavy chain polypeptide (H1) and a light chain polypeptide (L1), wherein the H1 comprises a VH domain (VH1) comprising the amino acid sequence of SEQ ID NO:
- 22 and the L1 comprises a VL domain (VL1) comprising the amino acid sequence of SEQ ID NO:
- 23.
Dependencies are inferred from the claim text.